EN
抗体药类似物
Research Grade Drozitumab
All
  • CatalogTD-HT348046
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsPRO95780,anti-DR5,rhuMAbDR5,CAS:912628-39-8
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Drozitumab


Catalog No. TD-HT348046
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-lambda
Expression system Mammalian Cells
Clonality Monoclonal
Target TRAILR2, TRAIL-R2, Death receptor 5, CD262, DR5, Tumor necrosis factor receptor superfamily member 10B, ZTNFR9, TRAIL receptor 2, TRICK2, TNFRSF10B, KILLER, TNF-related apoptosis-inducing ligand receptor 2
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession O14763
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names PRO95780,anti-DR5,rhuMAbDR5,CAS:912628-39-8
Background Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. Drozitumab has potent antitumor activity against rhabdomyosarcoma.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HT348046_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Drozitumab.